Vistusertib Uses, Dosage, Side Effects and more
Vistusertib is under investigation for the treatment of Advanced Gastric Adenocarcinoma.
| Attribute | Details |
|---|---|
| Trade Name | Vistusertib |
| Generic | Vistusertib |
| Vistusertib Other Names | Vistusertib |
| Type | |
| Formula | C25H30N6O3 |
| Weight | Average: 462.554 Monoisotopic: 462.23793885 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
